Introduction. Rhenium-188 has found wide application in nuclear medicine for the treatment of metastatic lesions skeletal system and joint diseases such as rheumatoid arthritis synovitis. Also, 188 Re-radiopharmaceuticals are being developed palliative hepatocellular carcinoma others. Immediately after first clinical trials Re-radiopharmaceuticals, when information on clinically effective admin...

Abstract This observational study was conducted owing to the challenges of positron emission tomography/magnetic resonance imaging (PET/MRI) that requires longer duration scanning radiopharmaceutical injected patient and added MRI environment. The aim this assess radiation dose at different distances from burden anesthesiologist other personnel in performing PET/MRI under general anesthesia or ...

Although neurological ailments continue to be some of the main causes of disease burden in the world, current therapies such as pharmacological agents have limited potential in the restoration of neural functions. Cell therapies, firstly applied to treat different hematological diseases, are now being investigated in preclinical and clinical studies for neurological illnesses. However, the pote...

according to the importance of positron emitters in nuclear medicine, 82mrb was produced as a member of this group of radiopharmaceuticals. after being converted into an injectable form, enough information was provided for imaging with this radiopharmaceutical. 82mrb with high radioisotopic purity and half-life of 6.5 hours, in chloride form, can be considered as a suitable positron emitter for...